Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-11 19:07:23 EDT

Explore

PostsPeople
LatestRanked
@sigtrans-sttt.bsky.socialOct 1, 2026, 12:20 PM

RAC1 #SUMOylation emerges as a druggable regulator of #BreastCancer #Metastasis. Blocking this switch with TAT-PRASI reduces RAC1 activity and RAC1–POTEE interaction, impairing invadopodia formation and metastatic invasion. @usaloficial.bsky.social @ucm.es
#STTT #OpenAccess: doi.org/10.1038/s413...

A RAC1 SUMOylation switch governs breast cancer metastasis
@sigtrans-sttt.bsky.socialOct 1, 2026, 7:42 AM

A multitarget strategy may help address #TNBC heterogeneity.

Opti-hTIF1γ suppresses β-catenin, TGFβ and STAT3 signaling while downregulating CD47 and CXCL5, enhancing #macrophage phagocytosis and #antitumoractivity.
#TumorMicroenvironment #CancerBiology
#STTT #OpenAccess: doi.org/10.1038/s413...

Transcriptional intermediary factor 1 gamma-based multitarget gene therapeutic strategy for triple-negative breast cancer
@sigtrans-sttt.bsky.socialOct 1, 2026, 7:37 AM

This study uncovers how polymeric #Alpha1Antitrypsin accumulation perturbs Paneth cell #Proteostasis via #ERstress and impaired lysosomal clearance, linking deficiency to severe intestinal inflammation.

#STTT #OpenAccess: doi.org/10.1038/s413...

Polymeric alpha-1 antitrypsin perturbs Paneth cell proteostasis and exacerbates intestinal inflammation
@sigtrans-sttt.bsky.socialSep 30, 2026, 3:30 PM

Learn how all-trans retinoic acid prevents CD8+ T-cell exhaustion and potentiates anti-PD-1 therapy in #Glioblastoma by activating WNT/β-catenin–TCF-1βBD signaling.

#STTT #OpenAccess: doi.org/10.1038/s413...
#CancerResearch #TranslationalMedicine

All-trans retinoic acid suppresses CD8+ T-cell terminal exhaustion and potentiates anti-PD-1 therapy in glioblastoma
@sigtrans-sttt.bsky.socialSep 30, 2026, 12:15 PM

How does macrophage zinc accumulation worsen #MASLD progression?

Macrophage zinc trapping activates IRE1α–XBP1s signaling, promoting IL-1β-driven #MetabolicReprogramming and lipid transfer to hepatocytes, driving liver inflammation.

#STTT #OpenAccess: doi.org/10.1038/s413...

Zinc accumulation in macrophages exacerbates metabolic dysfunction-associated steatotic liver disease progression
@sigtrans-sttt.bsky.socialSep 30, 2026, 8:30 AM

Quiescent #BreastCancer stem-like cells can reawaken in #TNBC.

New study in #STTT identifies an ENO1–lactate–H4K12la feedback loop that upregulates PCNA to activate qsBCSCs, revealing a metabolic–epigenetic axis linked to tumor growth.

#OpenAccess: doi.org/10.1038/s413...

Glycolytic enolase 1-induced H4K12 lactylation activates quiescent breast cancer stem-like cells in triple-negative breast cancer
@sigtrans-sttt.bsky.socialSep 30, 2026, 5:35 AM

The anti-TFRC antibody PPMX-T003 suppresses #ColorectalCancer growth and metastatic colonization in preclinical models, highlighting iron-dependent tumor survival as a target for limiting metastatic progression.

#STTT #OpenAccess: doi.org/10.1038/s413...
#AntibodyTherapy #TargetedTherapy

Clinical-stage human anti-transferrin receptor antibodies suppress colorectal cancer metastasis
@sigtrans-sttt.bsky.socialSep 29, 2026, 4:05 PM

Traditional #Biomarker discovery suffers from single-modality analyses, weak mechanistic foundations, and low reproducibility.

This review examines #AI approaches for precision diagnostics and targeted therapies.

#STTT #OpenAccess: doi.org/10.1038/s413...
#DrugDelivery

Artificial intelligence in biomarker discovery for diseases: diagnostic and therapeutic prospects
@sigtrans-sttt.bsky.socialSep 29, 2026, 12:40 PM

How can functional RNA molecules move beyond simple protein coding to power next-gen loss- and gain-of-function treatments? This review explores emerging druggable RNAs, optimization, and delivery systems for #clinicaltherapeutics.

#STTT #OpenAccess: doi.org/10.1038/s413...
#DrugDelivery

RNA therapeutics: current status and future directions
@sigtrans-sttt.bsky.socialSep 29, 2026, 9:15 AM

TKTL1-driven #Glycolysis increases lactate and promotes #Immunosuppressive dendritic-cell signaling in #HCC. Targeting the TKTL1–HIF-1α–HK2 axis and lactate reprograms the #TumorMicroenvironment to enhance PD-1 blockade.

#STTT #OpenAccess: doi.org/10.1038/s413...

Transketolase-like 1 potentiates PD-1 blockade in hepatocellular carcinoma by glycolysis to prime dendritic cell lactylation
@sigtrans-sttt.bsky.socialSep 29, 2026, 5:38 AM

Inotodiol activates LXRβ and promotes PPARδ-dependent #SIRT3 transcription, engaging the LXRβ/SIRT3/PGC-1α pathway to restore mitochondrial function and counter age-associated #MuscleWasting and #MetabolicDysfunction.

#STTT #OpenAccess: doi.org/10.1038/s413...

Inotodiol prevents age-related muscle wasting by restoring mitochondrial function through liver X receptor beta signaling
@sigtrans-sttt.bsky.socialSep 28, 2026, 3:45 PM

How do #Cuproptosis and #Ferroptosis intersect across disease?

This review connects metal metabolism, redox imbalance, organelle crosstalk, and regulatory networks with therapeutic strategies, #Biomarkers, and patient stratification.

#STTT #OpenAccess: doi.org/10.1038/s413...
#PrecisionOncology

Cuproptosis and ferroptosis: signal pathways, diseases and therapeutic targets
@sigtrans-sttt.bsky.socialSep 28, 2026, 1:00 PM

How can targeting synthetic lethal interactions revolutionize #Cancer treatment?
This review examines PARP, ATR, ATM, DNA-PK, and emerging non-DDR targets, while addressing resistance, combination strategies, and patient selection. @uab.cat #Biomarkers

#STTT #OpenAccess: doi.org/10.1038/s413...

Synthetic lethality in cancer: mechanisms, therapeutic exploitation and clinical translation
@sigtrans-sttt.bsky.socialSep 28, 2026, 10:00 AM

ADC development requires coordinated optimization of antigens, antibodies, linkers, and payloads. This review explores how AI and computational #Biophysics can guide rational design, patient stratification, #Pharmacokinetics, and dosing.#DrugDesign

#STTT #OpenAccess: doi.org/10.1038/s413...

Antibody-drug conjugate engineering: from design to efficacy and safety
@sigtrans-sttt.bsky.socialSep 28, 2026, 5:53 AM

#Cancer heterogeneity operates across interconnected biological scales. The HITET framework links them through niche–flow–feedback interactions to organize mechanisms, therapeutic strategies, and hypotheses for future validation.#CancerGenomics

#STTT #OpenAccess: doi.org/10.1038/s413...

Heterogeneity in cancer: molecular mechanisms and therapeutic strategies
@sigtrans-sttt.bsky.socialSep 27, 2026, 4:01 PM

#FractureRepair relies on coordinated immune, vascular, neural, and skeletal signaling. This review connects key mechanisms of #BoneHealing with targeted regenerative strategies and their translational challenges.

#STTT #OpenAccess: doi.org/10.1038/s413...
#MotorDysfunction #CellBiology

Fracture healing: from molecular and cellular mechanisms to therapeutic strategies
@sigtrans-sttt.bsky.socialSep 27, 2026, 12:30 PM

Can precision retinoid therapy overcome therapeutic resistance?

This review defines “retinoid endotypes” shaped by metabolic niches, chromatin state, and #microenvironmental cues to inform patient stratification and precision therapy.

#STTT #OpenAccess: doi.org/10.1038/s413...
#Immunology

@sigtrans-sttt.bsky.socialSep 27, 2026, 6:45 AM

USP2 inhibition destabilizes STUB1 to suppress pathological #Pexophagy in PEX1-deficient models, restoring peroxisome abundance while mitigating metabolic abnormalities, neuro-axonal pathology, and motor dysfunction.

#STTT #OpenAccess: doi.org/10.1038/s413...
#Neurobiology #MolecularMedicine

Inhibition of USP2 suppresses pathological pexophagy and rescues PEX1-deficient peroxisome biogenesis disorder
@sigtrans-sttt.bsky.socialSep 27, 2026, 3:15 AM

Researchers show that targeting BIRC6 disrupts a Treg-driven pathway that supports aged HSC survival, helping rebalance #hematopoiesis, reduce #Immunosenescence, and improve immune function in models of #Aging.

#STTT #OpenAccess: doi.org/10.1038/s413...
#Hematology #Immunology

Targeting BIRC6 rejuvenates hematopoietic stem cell aging and immunosenescence
@sigtrans-sttt.bsky.socialSep 26, 2026, 3:45 PM

Single-cell #Multiomics reveals that #TNBC-derived #Exosomes reshape T cells through regulatory and dysfunctional states, #miRNA-mediated immune suppression, and distinct γδ and αβ TCR clonotypic expansions.

#STTT #OpenAccess: doi.org/10.1038/s413...

Single-cell multiomics reveals exosome-mediated reprogramming and clonotypic remodeling of T cells in triple-negative breast cancer
Load more